|
IMMT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.47812881326581E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.00900407421045E-11 |
| Normal-vs-Stage2 |
7.978800E-01 |
| Normal-vs-Stage3 |
1.81854531433601E-12 |
| Normal-vs-Stage4 |
1.77059478190245E-11 |
| Stage1-vs-Stage2 |
5.079200E-03 |
| Stage1-vs-Stage3 |
2.657900E-02 |
| Stage1-vs-Stage4 |
3.070000E-02 |
| Stage2-vs-Stage3 |
3.222700E-04 |
| Stage2-vs-Stage4 |
2.010400E-04 |
| Stage3-vs-Stage4 |
6.783200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.99520433297585E-15 |
| Normal-vs-AfricanAmerican |
6.41120000000051E-05 |
| Normal-vs-Asian |
8.247700E-04 |
| Caucasian-vs-AfricanAmerican |
2.896800E-01 |
| Caucasian-vs-Asian |
4.449500E-02 |
| AfricanAmerican-vs-Asian |
6.806600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.56990042766392E-10 |
| Normal-vs-Female |
1.25439658660298E-11 |
| Male-vs-Female |
7.050200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.33499886093114E-11 |
| Normal-vs-Age(41-60Yrs) |
1.2604028931662E-11 |
| Normal-vs-Age(61-80Yrs) |
4.444500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.70259999999956E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.091400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.496800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.664400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.288430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.148000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.079200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.080500E-02 |
| Classical-VS-Follicular |
2.576400E-04 |
| Classical-VS-Other |
4.825600E-01 |
| Classical-VS-Normal |
1.31339383813156E-13 |
| Tall-VS-Follicular |
3.25430000003291E-06 |
| Tall-VS-Other |
6.984000E-01 |
| Tall-VS-Normal |
4.94948526608141E-12 |
| Follicular-VS-Other |
1.187610E-01 |
| Follicular-VS-Normal |
1.724030E-01 |
| Other-VS-Normal |
2.724200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.84019999741147E-08 |
| Normal-vs-N1 |
1.11022302462516E-16 |
| N0-vs-N1 |
1.47109999959483E-07 |
|
|
